Shop

“Article: P.10 Role of HH pathway in T cell acute lymphoblastic leukaemia (T-ALL)” has been added to your cart. View cart

Showing 1089–1104 of 1900 results

Article: P.08 Comparison of Long-Term Outcome between Belgian and Vietnamese Children Treated for Acute Lymphoblastic Leukaemia according to Fralle 2000 protocol
€2.42 Add to cart
Article: P.09 Exome sequencing identifies mutation of CNOT3 in T-cell acute lymphoblastic leukaemia
€2.42 Add to cart
Article: P.10 Role of HH pathway in T cell acute lymphoblastic leukaemia (T-ALL)
€2.42 Add to cart
Article: P.11 Expression of ZAP-70 in CLL activates NF-?B signaling
€2.42 Add to cart
Article: P.12 Evaluation of CD200 expression in differential diagnosis of CD5+ B cell NHLs
€2.42 Add to cart
Article: P.13 G8 as a screening tool for older patients with malignant haemopathies: A surrogate for CGA?
€2.42 Add to cart
Article: P.14 Bendamustin shows distinct anti-tumoural responses in multiple myeloma patients that relapsed after prior bortezomib and lenalidomide treatment. A study on behalf of the MM BHS subcommittee
€2.42 Add to cart
Article: P.14.2 KIT D816 mutation in myeloid neoplasms: look out for systemic mastocytosis associated hematologic neoplasms (SM-AHN)
€2.42 Add to cart
Article: P.15 Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL): The Lymphoma Study Association (LYSA) Registry Data
€2.42 Add to cart
Article: P.15 Genomic profiling of myeloma: A comparison of cytogenetics, FISH and array- CGH analysis of 95 cases at diagnosis or follow up
€2.42 Add to cart
Article: P.16 Expression of TMEM45A, a candidate gene of chemoresistance, in a panel of neoplastic tissues
€2.42 Add to cart
Article: P.16 Malignant invasion of the cerebrospinal fluid in patients with a haematological malignancy: a single center retrospective study
€2.42 Add to cart
Article: P.17 Complete responses of the TEMPI syndrome to bortezomib
€2.42 Add to cart
Article: P.17 Feasibility of next generation flow for minimal residual disease in multiple myeloma on a BD FACS Lyric flowcytometer
€2.42 Add to cart
Article: P.18 Concurrent B-cell chronic lymphocytic leukaemia and multiple myeloma
€2.42 Add to cart
Article: P.18 Daratumumab therapy in patients with immunoglobulin light chain amyloidosis, a single center experience
€2.42 Add to cart

Article: P.08 Comparison of Long-Term Outcome between Belgian and Vietnamese Children Treated for Acute Lymphoblastic Leukaemia according to Fralle 2000 protocol

Article: P.09 Exome sequencing identifies mutation of CNOT3 in T-cell acute lymphoblastic leukaemia

Article: P.10 Role of HH pathway in T cell acute lymphoblastic leukaemia (T-ALL)

Article: P.11 Expression of ZAP-70 in CLL activates NF-?B signaling

Article: P.12 Evaluation of CD200 expression in differential diagnosis of CD5+ B cell NHLs

Article: P.13 G8 as a screening tool for older patients with malignant haemopathies: A surrogate for CGA?

Article: P.14 Bendamustin shows distinct anti-tumoural responses in multiple myeloma patients that relapsed after prior bortezomib and lenalidomide treatment. A study on behalf of the MM BHS subcommittee

Article: P.14.2 KIT D816 mutation in myeloid neoplasms: look out for systemic mastocytosis associated hematologic neoplasms (SM-AHN)

Article: P.15 Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL): The Lymphoma Study Association (LYSA) Registry Data

Article: P.15 Genomic profiling of myeloma: A comparison of cytogenetics, FISH and array- CGH analysis of 95 cases at diagnosis or follow up

Article: P.16 Expression of TMEM45A, a candidate gene of chemoresistance, in a panel of neoplastic tissues

Article: P.16 Malignant invasion of the cerebrospinal fluid in patients with a haematological malignancy: a single center retrospective study

Article: P.17 Complete responses of the TEMPI syndrome to bortezomib

Article: P.17 Feasibility of next generation flow for minimal residual disease in multiple myeloma on a BD FACS Lyric flowcytometer

Article: P.18 Concurrent B-cell chronic lymphocytic leukaemia and multiple myeloma

Article: P.18 Daratumumab therapy in patients with immunoglobulin light chain amyloidosis, a single center experience